CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Pharmathene, Inc  (PIP)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Pharmathene Inc's Quick Ratio

PIP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

PIP Quick Ratio (Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
(Sep 30 2015)
III. Quarter
Y / Y Current Liabilities Change 56.61 % -2.01 % -41.81 % -15.59 % 78.72 %
Y / Y Cash & cash equivalent Change 681.79 % 25.78 % -9.47 % -16.49 % -11.37 %
Quick Ratio MRQ 36.46 7.08 5.39 7.14 7.3
Overall Ranking # 80 # 422 # 559 # 475 # 504
Seq. Current Liabilities Change 14.07 % 23.81 % 21.14 % -8.46 % -28.62 %
Seq. Cash & cash equivalent Change 487.05 % 62.68 % -8.57 % -10.46 % -5.55 %



Quick Ratio third quarter 2016 Comment
Pharmathene Inc's Cash & cash equivalent grew by 487.05 % in III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Pharmathene Inc's Quick Ratio to 36.46, Quick Ratio remained below Pharmathene, Inc average.

Within Major Pharmaceutical Preparations industry 4 other companies have achieved higher Quick Ratio than Pharmathene Inc in third quarter 2016. While Quick Ratio total ranking has improved so far to 80, from total ranking in previous quarter at 422.

Explain Quick Ratio?
What are PIP Segments?
See Quick Ratio PIP on the trailing twelve month basis
Quick Ratio third quarter 2016 Company Ranking
Within: No.
Industry # 5
Sector # 9
S&P 500 # 80


Quick Ratio Statistics
High Average Low
36.46 7.39 2.46
(Sep 30 2016)   (Dec 31 2012)


You need to upgrade your Flash Player


Financial Statements
Pharmathene Inc's Current Liabilities $ 4 Millions Visit PIP's Balance sheet
Pharmathene Inc's Cash & cash equivalent $ 136 Millions Visit PIP's Balance sheet
Source of PIP's Sales Visit PIP's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2016, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2016 MRQ Cash & cash equivalentSep 30 2016 MRQ Current Liabilities
Medicinova Inc  94.01 $ 24.972  Millions$ 0.266  Millions
Enanta Pharmaceuticals Inc  62.21 $ 210.084  Millions$ 3.377  Millions
Flex Pharma, Inc.  49.38 $ 67.334  Millions$ 1.364  Millions
Esperion Therapeutics, Inc.  36.78 $ 210.101  Millions$ 5.713  Millions
Pharmathene, Inc  36.46 $ 135.949  Millions$ 3.729  Millions
Endocyte Inc  32.24 $ 146.717  Millions$ 4.551  Millions
Achillion Pharmaceuticals Inc  29.70 $ 408.705  Millions$ 13.761  Millions
Chimerix Inc  25.96 $ 249.673  Millions$ 9.618  Millions
Loxo Oncology, Inc.  23.37 $ 155.537  Millions$ 6.654  Millions
Inotek Pharmaceuticals Corporation  23.15 $ 137.583  Millions$ 5.944  Millions
Catalyst Pharmaceuticals, Inc.  22.42 $ 44.744  Millions$ 1.996  Millions
Dipexium Pharmaceuticals, Inc.  21.21 $ 18.891  Millions$ 0.891  Millions
Prothena Corp Plc  20.46 $ 408.574  Millions$ 19.971  Millions
Clearside Biomedical, Inc.  19.44 $ 56.919  Millions$ 2.928  Millions
Biospecifics Technologies Corp  19.37 $ 49.823  Millions$ 2.573  Millions
Sage Therapeutics, Inc.  19.31 $ 431.270  Millions$ 22.330  Millions
Carbylan Therapeutics, Inc.  18.62 $ 35.208  Millions$ 1.891  Millions
Lipocine Inc.  18.34 $ 28.839  Millions$ 1.572  Millions
Arbutus Biopharma Corp  17.84 $ 149.682  Millions$ 8.392  Millions
Aeglea Biotherapeutics, Inc.  17.73 $ 68.035  Millions$ 3.837  Millions
Xenon Pharmaceuticals Inc.  17.48 $ 69.491  Millions$ 3.976  Millions
Aquinox Pharmaceuticals, Inc  17.04 $ 145.936  Millions$ 8.564  Millions
Otonomy, Inc.  16.99 $ 215.264  Millions$ 12.673  Millions
Qlt Inc  16.73 $ 73.056  Millions$ 4.366  Millions
Epizyme, Inc.  16.61 $ 263.343  Millions$ 15.855  Millions
Global Blood Therapeutics, Inc.  16.56 $ 217.837  Millions$ 13.157  Millions
Nexvet Biopharma Plc  16.49 $ 24.550  Millions$ 1.489  Millions
Sophiris Bio Inc.  15.93 $ 31.258  Millions$ 1.962  Millions
Concert Pharmaceuticals, Inc.  15.66 $ 107.992  Millions$ 6.898  Millions
Geron Corp  14.87 $ 108.806  Millions$ 7.319  Millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
RVEN's Profile
Stock Price
RVEN's Financials
RVEN's Expectations
Business Description
Fundamentals
Charts & Quotes
RVEN's News
Suppliers
RVEN's Competitors
Customers & Markets
Economic Indicators
RVEN's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com